Rediff #Suven-Life-Sciences-Ltd
reports Q4 numbers with sales at Rs 74.7 crore vs Rs 62.9 crore, (YoY). (ET Now) #Earnings
#money
Rediff #Suven-Life-Sciences-Ltd
reports Q4 numbers with PAT at Rs 8.6 crore & FY13 PAT is Rs 30.8 crore. (ET Now) #Earnings
#money
Rediff #Suven-Life-Sciences-Ltd
secures 3 products patents in Canada and Eurasia. (ET Now) #money
kripa shankar oye yar its a really multibeggar company in future it would reach rs 500 in 3 years only. #Suven-Life-Sciences-Ltd
#money
Rediff Buy #Suven-Life-Sciences-Ltd
with a target of Rs 35 & stop loss of Rs 26- Ashwani Gujral, technical analyst. (ET Now) #money
shankar mondal buy suven life 30 next target #Suven-Life-Sciences-Ltd
#money
Rediff #Suven-Life-Sciences-Ltd
: We are exploring options to raise funds. (CNBC TV18) #money
sandeep parekhKripa shankarji Ye share 6 month main ktna jayega??
kishor dhandhukia Sell suven life it will not cross rs 28 #Suven-Life-Sciences-Ltd
#money
kripa shankar Buy target 4 ths week @30 #Suven-Life-Sciences-Ltd
#money